These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24062505)

  • 1. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
    Terplan M; Zuckerman D
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304. PubMed ID: 24062505
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
    Bitzer J
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304-5. PubMed ID: 24062506
    [No Abstract]   [Full Text] [Related]  

  • 3. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):156-9. PubMed ID: 23585363
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274
    [No Abstract]   [Full Text] [Related]  

  • 5. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hormonal contraception and risk of venous thromboembolism.
    Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of thromboembolism and use of combined oral contraceptives: a comment.
    Birkhäuser M; Böttcher B; Germeyer A; Hadji P; Imthurn B; Mueck AO; Neulen J; Stute P; Thaler CJ; Wiegratz I; Wildt L
    BJOG; 2023 Jun; 130(7):844-845. PubMed ID: 36890428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
    Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
    Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Venous thromboembolism and oral contraception].
    Veljković M; Popovć J
    Med Pregl; 2010; 63(5-6):376-9. PubMed ID: 21186550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.